Appendix Table 1.
Antidepressant, Antipsychotic, and Cholinesterase Inhibitor Medications Currently Used at the Time of Randomized Enrollment among Dual-eligible Nursing Home Residents, 2006–2008
| MEDICATION CLASS | DRUG | CURRENT USERS (#) | CURRENT USERS (%) |
|---|---|---|---|
| Antidepressants | |||
| Amitriptyline HCl Tablet | 680 | 0.96% | |
| Amoxapine Tablet | 7 | 0.01% | |
| Bupropion HCl Sustained Release Tablet | 520 | 0.74% | |
| Bupropion HCl Sustained Release Tablet Xl | 245 | 0.35% | |
| Bupropion HCl Tablet | 353 | 0.50% | |
| Citalopram Hydrobromide Reformulation Solution | 89 | 0.13% | |
| Citalopram Hydrobromide Reformulation Tablet | 17193 | 24.33% | |
| Citalopram Hydrobromide Solution | 53 | 0.08% | |
| Citalopram Hydrobromide Tablet | 5252 | 7.43% | |
| Clomipramine HCl Capsule | 51 | 0.07% | |
| Desipramine HCl Tablet | 42 | 0.06% | |
| Duloxetine HCl Delayed Release Capsule | 1740 | 2.46% | |
| Fluoxetine HCl Delayed Release Capsule | 76 | 0.11% | |
| Fluoxetine HCl Solution | 99 | 0.14% | |
| Fluoxetine HCl Tablet | 3211 | 4.54% | |
| Fluvoxamine Maleate Tablet | 230 | 0.33% | |
| Imipramine HCl Tablet | 110 | 0.16% | |
| Imipramine Pamoate Capsule | 1 | 0.00% | |
| Maprotiline HCl Tablet | 5 | 0.01% | |
| Mirtazapine Dissolvable Tablet | 4350 | 6.16% | |
| Mirtazapine Tablet | 9279 | 13.13% | |
| Nefazodone HCl Tablet | 26 | 0.04% | |
| Nortriptyline HCl Capsule | 564 | 0.80% | |
| Nortriptyline HCl Solution | 6 | 0.01% | |
| Paroxetine HCl Reformulation Tablet | 34 | 0.05% | |
| Paroxetine HCl Suspension | 33 | 0.05% | |
| Paroxetine HCl Sustained Release Tablet | 282 | 0.40% | |
| Paroxetine HCl Tablet | 4783 | 6.77% | |
| Phenelzine Sulfate Tablet | 7 | 0.01% | |
| Protriptyline HCl Tablet | 4 | 0.01% | |
| Selegiline Patch/Disc | 5 | 0.01% | |
| Sertraline HCl Suspension | 61 | 0.09% | |
| Sertraline HCl Tablet | 13177 | 18.65% | |
| Tranylcypromine Sulfate Tablet | 1 | 0.00% | |
| Trazodone HCl Tablet | 4312 | 6.10% | |
| Trimipramine Maleate Capsule | 2 | 0.00% | |
| Venlafaxine HCl Continuous Delivery Caps | 2792 | 3.95% | |
| Venlafaxine HCl Tablet | 987 | 1.40% | |
| Atypical Antipsychotics | |||
| Aripiprazole Dissolvable Tablet | 1 | 0.00% | |
| Aripiprazole Solution | 16 | 0.04% | |
| Aripiprazole Tablet | 1756 | 4.03% | |
| Clozapine Dissolvable Tablet | 18 | 0.04% | |
| Clozapine Tablet | 322 | 0.74% | |
| Haloperidol Suspension | 52 | 0.12% | |
| Haloperidol Tablet | 1252 | 2.87% | |
| Loxapine Succinate Capsule | 56 | 0.13% | |
| Molindone HCl Tablet | 22 | 0.05% | |
| Olanzapine Dissolvable Tablet | 998 | 2.29% | |
| Olanzapine Tablet | 10183 | 23.37% | |
| Quetiapine Fumarate Sustained Release Tablet | 1 | 0.00% | |
| Quetiapine Fumarate Tablet | 14041 | 32.22% | |
| Risperidone Dissolvable Tablet | 180 | 0.41% | |
| Risperidone Solution | 497 | 1.14% | |
| Risperidone Sustained Release Tablet | 7 | 0.02% | |
| Risperidone Tablet | 13391 | 30.73% | |
| Thiothixene Capsule | 100 | 0.23% | |
| Ziprasidone HCl Capsule | 685 | 1.57% | |
| Cholinesterase Inhibitors* | |||
| Donepezil HCl Dissolvable Tablet | 112 | 0.29% | |
| Donepezil HCl Tablet | 29196 | 76.43% | |
| Galantamine Hydrobromide Solution | 20 | 0.05% | |
| Galantamine Hydrobromide Sustained Release | 1408 | 3.69% | |
| Capsule | |||
| Galantamine Hydrobromide Tablet | 3326 | 8.71% | |
| Rivastigmine Patch/Disc | 27 | 0.07% | |
| Rivastigmine Tartrate Capsule | 4082 | 10.69% | |
| Rivastigmine Tartrate Solution | 28 | 0.07% |
*
Namenda is a NMDA agonist and not a cholinesterase inhibitor; thus, it is not included in our analyses.